CASC2 and hepatocellular carcinoma: Palmieri et al. confirmed that CASC2 can inhibit EMT of HCC cells, achieve the purpose of inhibiting migration, invasion, and proliferation of HCC cells, and promote apoptosis of HCC cells by effectively inhibiting MAPK signaling pathway [109].